Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4

被引:12
|
作者
Perpina-Viciano, Cristina [1 ,2 ]
Isbilir, Ali [2 ,3 ]
Zarca, Aurelien [4 ]
Caspar, Birgit [5 ,6 ,7 ]
Kilpatrick, Laura E. [5 ,6 ,7 ]
Hill, Stephen J. [5 ,6 ,7 ]
Smit, Martine J. [4 ]
Lohse, Martin J. [2 ,3 ]
Hoffmann, Carsten [1 ,2 ]
机构
[1] Univ Jena, Univ Hosp Jena, Inst Mol Cell Biol, Ctr Mol Biomed CMB, Hans Knoll Str 2, D-07745 Jena, Germany
[2] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany
[3] Max Delbruck Ctr Mol Med, Berlin, Germany
[4] Vrije Univ, Amsterdam Inst Mol Med & Syst AIMMS, Div Med Chem, Amsterdam, Netherlands
[5] Univ Nottingham, Queens Med Ctr, Med Sch, Div Physiol Pharmacol & Neurosci,Sch Life Sci, Nottingham, England
[6] Univ Birmingham, Ctr Membrane Prot & Receptors Compare, The Midlands, England
[7] Univ Nottingham, The Midlands, England
基金
英国医学研究理事会; 欧盟地平线“2020”;
关键词
PROTEIN-COUPLED RECEPTOR; PARATHYROID-HORMONE RECEPTOR; CRYSTAL-STRUCTURE; RESIDENCE TIME; SMALL-MOLECULE; ACTIVATION; GPCR; MIGRATION; CANCER; LIGAND;
D O I
10.1124/mol.119.118448
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
G protein-coupled receptors (GPCRs) are biologic switches that transduce extracellular stimuli into intracellular responses in the cell. Temporally resolving GPCR transduction pathways is key to understanding how cell signaling occurs. Here, we investigate the kinetics and dynamics of the activation and early signaling steps of the CXC chemokine receptor (CXCR) 4 in response to its natural ligands CXC chemokine ligand (CXCL) 12 and macrophage migration inhibitory factor (MIF), using Forster resonance energy transfer-based approaches. We show that CXCR4 presents a multifaceted response to CXCL12, with receptor activation (approximate to 0.6 seconds) followed by a rearrangement in the receptor/G protein complex (approximate to 1 seconds), a slower dimer rearrangement (approximate to 1.7 seconds), and prolonged G protein activation (RA seconds). In comparison, MIF distinctly modulates every step of the transduction pathway, indicating distinct activation mechanisms and reflecting the different pharmacological properties of these two ligands. Our study also indicates that CXCR4 exhibits some degree of ligand-independent activity, a relevant feature for drug development. SIGNIFICANCE STATEMENT The CXC chemokine ligand (CXCL) 12/CXC chemokine receptor (CXCR) 4 axis represents a well-established therapeutic target for cancer treatment. We demonstrate that CXCR4 exhibits a multifaceted response that involves dynamic receptor dimer rearrangements and that is kinetically embedded between receptor-G protein complex rearrangements and G protein activation. The alternative endogenous ligand macrophage migration inhibitory factor behaves opposite to CXCL12 in each assay studied and does not lead to G protein activation. This detailed understanding of the receptor activation may aid in the development of more specific drugs against this target.
引用
收藏
页码:72 / 87
页数:16
相关论文
共 50 条
  • [31] Human Bετα Defensin Type 3 Interaction with Chemokine Receptor CXCR4
    Zhang, Liqun
    Weinberg, Aaron
    Feng, Zhiming
    [J]. BIOPHYSICAL JOURNAL, 2017, 112 (03) : 389A - 389A
  • [32] The US27 gene product of human cytomegalovirus enhances signaling of host chemokine receptor CXCR4
    Arnolds, Kathleen L.
    Lares, Angela P.
    Spencer, Juliet V.
    [J]. VIROLOGY, 2013, 439 (02) : 122 - 131
  • [33] Oligomeric structure of the CXCR4 chemokine receptor determined by fluorescence fluctuation analysis
    Ward, Richard
    Pediani, John
    Milligan, Graeme
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2530 - 2531
  • [34] CXC chemokine receptor 4 (CXCR4) functions as a lactoferrin receptor in macrophages
    Takayama, Y.
    Aoki, R.
    [J]. FEBS OPEN BIO, 2018, 8 : 376 - 376
  • [35] CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy
    Bhangoo, Sonia K.
    Ren, Dongjun
    Miller, Richard J.
    Chan, David M.
    Ripsch, Matthew S.
    Weiss, Clarissa
    McGinnis, Christian
    White, Fletcher A.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2007, 21 (05) : 581 - 591
  • [36] Gambogic acid inhibits chemokine receptor CXCR4 signaling pathways and osteoclastogenesis in multiple myeloma
    Pandey, Manoj K.
    Kale, Vijay P.
    Song, Chunhua
    Sung, Shen-Shu
    Sharma, Arun K.
    Dovat, Sinisa
    Amin, Shantu G.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [37] Short-term cellular memory tunes the signaling responses of the chemokine receptor CXCR4
    Spinosa, Phillip C.
    Humphries, Brock A.
    Mejia, Daniela Lewin
    Buschhaus, Johanna M.
    Linderman, Jennifer J.
    Luker, Gary D.
    Luker, Kathryn E.
    [J]. SCIENCE SIGNALING, 2019, 12 (589)
  • [38] Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)
    Woodard, Lauren E.
    De Silva, Ravindra A.
    Azad, Babak Behnam
    Lisok, Ala
    Pullambhatla, Mrudula
    Lesniak, Wojciech G.
    Mease, Ronnie C.
    Pomper, Martin G.
    Nimmagadda, Sridhar
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2014, 41 (07) : 552 - 561
  • [39] Chemokine receptor 4 (CXCR4) is part of the lipopolysaccharide "sensing apparatus"
    Triantafilou, Martha
    Lepper, Philipp M.
    Briault, Caspar David
    Ahmed, Mohamed Abd Elrahman
    Dmochowski, Josh M.
    Schumann, Christian
    Triantafilou, Kathy
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (01) : 192 - 203
  • [40] Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4)
    Oishi, Shinya
    Fujii, Nobutaka
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (30) : 5720 - 5731